89 related articles for article (PubMed ID: 8045836)
1. Responses to pressure and vasoactive agents by isolated pulmonary arteries from monocrotaline-treated rats.
Madden JA; Keller PA; Effros RM; Seavitte C; Choy JS; Hacker AD
J Appl Physiol (1985); 1994 Apr; 76(4):1589-93. PubMed ID: 8045836
[TBL] [Abstract][Full Text] [Related]
2. L-arginine-related responses to pressure and vasoactive agents in monocrotaline-treated rat pulmonary arteries.
Madden JA; Keller PA; Choy JS; Alvarez TA; Hacker AD
J Appl Physiol (1985); 1995 Aug; 79(2):589-93. PubMed ID: 7592222
[TBL] [Abstract][Full Text] [Related]
3. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
Altiere RJ; Olson JW; Gillespie MN
J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
[TBL] [Abstract][Full Text] [Related]
4. Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats.
Dhein S; Giessler C; Heinroth-Hoffmann I; Leineweber K; Seyfarth T; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):87-95. PubMed ID: 11819025
[TBL] [Abstract][Full Text] [Related]
5. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
[TBL] [Abstract][Full Text] [Related]
6. JTV-506, a new K(ATP) channel opener, relaxes pulmonary artery isolated from monocrotaline-treated pulmonary hypertensive rats.
Tsutsumi Y; Makita T; Yamaguchi K; Shibata O; Sumikawa K
J Anesth; 2004; 18(3):210-5. PubMed ID: 15290421
[TBL] [Abstract][Full Text] [Related]
7. Altered function of pulmonary endothelium following monocrotaline-induced lung vascular injury in rats.
Ito K; Nakashima T; Murakami K; Murakami T
Br J Pharmacol; 1988 Aug; 94(4):1175-83. PubMed ID: 3145089
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension.
van Suylen RJ; Smits JF; Daemen MJ
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1423-8. PubMed ID: 9603118
[TBL] [Abstract][Full Text] [Related]
9. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
Zhang MF; Liu XR; Yang N; Lin MJ
Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
[TBL] [Abstract][Full Text] [Related]
10. [Effect of chronic administration of aminoguanidine on the reactivity of pulmonary vessels in rats with monocrotaline-induced pulmonary hypertension].
Bonartsev AP; Slavutskaia Av; Postnikov AB; Medvedeva NA
Ross Fiziol Zh Im I M Sechenova; 2004 Jul; 90(7):908-15. PubMed ID: 15462215
[TBL] [Abstract][Full Text] [Related]
11. Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats.
Ozturk EI; Uma S
J Cardiovasc Pharmacol; 2010 Nov; 56(5):498-505. PubMed ID: 20729759
[TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
Mathew R; Zeballos GA; Tun H; Gewitz MH
Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
[TBL] [Abstract][Full Text] [Related]
13. Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.
Gur S; Kadowitz PJ; Thammasitboon S; Lasky JA; Hellstrom WJ
J Androl; 2009; 30(5):495-504. PubMed ID: 19201699
[TBL] [Abstract][Full Text] [Related]
14. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs.
Gillespie MN; Dyer KK; Olson JW; O'Connor WN; Altiere RJ
Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):365-78. PubMed ID: 3936139
[TBL] [Abstract][Full Text] [Related]
15. Adipose-derived stem cells attenuate pulmonary arterial hypertension and ameliorate pulmonary arterial remodeling in monocrotaline-induced pulmonary hypertensive rats.
Luo L; Lin T; Zheng S; Xie Z; Chen M; Lian G; Xu C; Wang H; Xie L
Clin Exp Hypertens; 2015; 37(3):241-8. PubMed ID: 25271670
[TBL] [Abstract][Full Text] [Related]
16. KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel.
Dai ZK; Cheng YJ; Chung HH; Wu JR; Chen IJ; Wu BN
Life Sci; 2010 May; 86(19-20):747-55. PubMed ID: 20303989
[TBL] [Abstract][Full Text] [Related]
17. Endothelin and 5-hydroxytryptamine on rat pulmonary artery in pulmonary hypertension.
Wanstall JC; O'Donnell SR
Eur J Pharmacol; 1990 Feb; 176(2):159-68. PubMed ID: 2107090
[TBL] [Abstract][Full Text] [Related]
18. A novel Ca2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension.
Pereira SL; Kummerle AE; Fraga CA; Barreiro EJ; Rocha Nde N; Ferraz EB; do Nascimento JH; Sudo RT; Zapata-Sudo G
Eur J Pharmacol; 2013 Feb; 702(1-3):316-22. PubMed ID: 23399770
[TBL] [Abstract][Full Text] [Related]
19. Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness.
Colice GL; Hill N; Lee YJ; Du H; Klinger J; Leiter JC; Ou LC
J Appl Physiol (1985); 1997 Jul; 83(1):25-31. PubMed ID: 9216940
[TBL] [Abstract][Full Text] [Related]
20. Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats.
Gillespie MN; Olson JW; Reinsel CN; O'Connor WN; Altiere RJ
Am J Physiol; 1986 Jul; 251(1 Pt 2):H109-14. PubMed ID: 2942040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
